Guangsu Xiong
Yueyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Efficacy of Chinese medicine WW-1 in managing gastric atrophy and intestinal metaplasia in patients with chronic atrophic gastritis: A multicenter, randomized, double-blind, placebo-controlled trial" [Pharmacol. Res. 227 (2026) 108176].
Journal: Pharmacological research
Published: May 25, 2026
Efficacy of Chinese medicine WW-1 in managing gastric atrophy and intestinal metaplasia in patients with chronic atrophic gastritis: A multicenter, randomized, double-blind, placebo-controlled trial.
Journal: Pharmacological research
Published: February 03, 2026
Nuclear receptors-mediated lipid metabolism dysregulation: A potential mechanism linking PFOA/PFOS to hepatocellular carcinoma.
Journal: Ecotoxicology and environmental safety
Published: July 21, 2025
Corrigendum: Canmei formula reduces colitis-associated colorectal carcinogenesis in mice by modulating the composition of gut microbiota.
Journal: Frontiers in oncology
Published: April 10, 2025
FIT-based risk-stratification model effectively screens colorectal neoplasia and early-onset colorectal cancer in Chinese population: a nationwide multicenter prospective study.
Journal: Journal of hematology & oncology
Published: August 04, 2022
Canmei Formula Reduces Colitis-Associated Colorectal Carcinogenesis in Mice by Modulating the Composition of Gut Microbiota.
Journal: Frontiers in oncology
Published: August 09, 2019
Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: December 28, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026